1. Home
  2. TLS vs CYBN Comparison

TLS vs CYBN Comparison

Compare TLS & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLS
  • CYBN
  • Stock Information
  • Founded
  • TLS 1969
  • CYBN 2019
  • Country
  • TLS United States
  • CYBN Canada
  • Employees
  • TLS 519
  • CYBN N/A
  • Industry
  • TLS EDP Services
  • CYBN Pharmaceuticals and Biotechnology
  • Sector
  • TLS Technology
  • CYBN Health Care
  • Exchange
  • TLS Nasdaq
  • CYBN Nasdaq
  • Market Cap
  • TLS 209.4M
  • CYBN 178.7M
  • IPO Year
  • TLS 2020
  • CYBN N/A
  • Fundamental
  • Price
  • TLS $2.73
  • CYBN $7.50
  • Analyst Decision
  • TLS Buy
  • CYBN Strong Buy
  • Analyst Count
  • TLS 6
  • CYBN 4
  • Target Price
  • TLS $3.94
  • CYBN $85.00
  • AVG Volume (30 Days)
  • TLS 673.5K
  • CYBN 503.1K
  • Earning Date
  • TLS 08-08-2025
  • CYBN 08-07-2025
  • Dividend Yield
  • TLS N/A
  • CYBN N/A
  • EPS Growth
  • TLS N/A
  • CYBN N/A
  • EPS
  • TLS N/A
  • CYBN N/A
  • Revenue
  • TLS $109,269,000.00
  • CYBN N/A
  • Revenue This Year
  • TLS $35.76
  • CYBN N/A
  • Revenue Next Year
  • TLS $26.83
  • CYBN N/A
  • P/E Ratio
  • TLS N/A
  • CYBN N/A
  • Revenue Growth
  • TLS N/A
  • CYBN N/A
  • 52 Week Low
  • TLS $1.83
  • CYBN $4.81
  • 52 Week High
  • TLS $4.82
  • CYBN $13.88
  • Technical
  • Relative Strength Index (RSI)
  • TLS 44.26
  • CYBN 45.63
  • Support Level
  • TLS $2.79
  • CYBN $7.55
  • Resistance Level
  • TLS $2.93
  • CYBN $8.18
  • Average True Range (ATR)
  • TLS 0.15
  • CYBN 0.43
  • MACD
  • TLS -0.02
  • CYBN -0.02
  • Stochastic Oscillator
  • TLS 14.29
  • CYBN 16.99

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

Share on Social Networks: